New insights into the pathophysiology of diabetic retinopathy: potential cell-specific therapeutic targets.
Journal
  Diabetes technology & therapeutics.
Citation
  Diabetes Technol Ther. 2(4):601-8
Publication date
  2000
Authors
  Gardner TW
Antonetti DA
Barber AJ
LaNoue KF
Nakamura M
Investigators
  David A. Antonetti
Alistair J. Barber
Thomas W. Gardner
Kathryn F. LaNoue
Grant agencies
  National Eye Institute
Grants
  NEI R01 EY12021
MeSH headings
  Diabetes Mellitus
Diabetic Retinopathy
MeSH qualifiers
  physiopathology
therapy
Abstract
  Diabetic retinopathy, a leading cause of vision impairment, is classically defined by its vascular lesions. This review examines how diabetes affects vascular cells, as well as neurons, macroglia, and microglia. The cellular and clinical elements of diabetic retinopathy have many features of chronic inflammation. Understanding the individual cell-specific and global inflammatory changes in the retina may lead to novel therapeutic approaches to prevent vision loss.
Medline ID
  21362271